229 related articles for article (PubMed ID: 10535471)
21. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
22. The impact of previous HBV infection on the course of chronic hepatitis C.
De Maria N; Colantoni A; Friedlander L; Leandro G; Idilman R; Harig J; Van Thiel DH
Am J Gastroenterol; 2000 Dec; 95(12):3529-36. PubMed ID: 11151889
[TBL] [Abstract][Full Text] [Related]
23. Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
Potthoff A; Deterding K; Trautwein C; Rifai K; Manns MP; Wedemeyer H
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):906-9. PubMed ID: 17873617
[TBL] [Abstract][Full Text] [Related]
24. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
Takkenberg B; Terpstra V; Zaaijer H; Weegink C; Dijkgraaf M; Jansen P; Beld M; Reesink H
J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
[TBL] [Abstract][Full Text] [Related]
25. Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy.
Kondo Y; Ueno Y; Ninomiya M; Tamai K; Tanaka Y; Inoue J; Kakazu E; Kobayashi K; Kimura O; Miura M; Yamamoto T; Kobayashi T; Igarashi T; Shimosegawa T
J Gastroenterol; 2012 Dec; 47(12):1323-35. PubMed ID: 22588246
[TBL] [Abstract][Full Text] [Related]
26. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
27. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
[TBL] [Abstract][Full Text] [Related]
28. Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy.
Saitta C; Pontisso P; Brunetto MR; Fargion S; Gaeta GB; Niro GA; Picciotto A; Smedile A; Squadrito G; Raimondo G
Antivir Ther; 2006; 11(7):931-4. PubMed ID: 17302256
[TBL] [Abstract][Full Text] [Related]
29. Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study.
Dikici B; Ozgenc F; Kalayci AG; Targan S; Ozkan T; Selimoglu A; Doganci T; Kansu A; Tosun S; Arslan N; Kasirga E; Bosnak M; Haspolat K; Buyukgebiz B; Aydogdu S; Girgin N; Yagci RV
J Gastroenterol Hepatol; 2004 Feb; 19(2):127-33. PubMed ID: 14731120
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients.
Chen CH; Lee CM; Hung CH; Wang JH; Hu TH; Changchien CS; Lu SN
J Gastroenterol Hepatol; 2011 Mar; 26(3):461-8. PubMed ID: 21332543
[TBL] [Abstract][Full Text] [Related]
31. No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.
Wei L; Wedemeyer H; Liaw YF; Chan HL; Piratvisuth T; Marcellin P; Jia J; Tan D; Chow WC; Brunetto MR; Diago M; Gurel S; Morozov V; He H; Zhu Y; Wat C; Surujbally B; Thompson AJ
PLoS One; 2018; 13(7):e0199198. PubMed ID: 30016335
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.
Akman SA; Okcu SC; Halicioğlu O; Sutcuoglu S; Anil M; Kizilgunesler A; Bakiler AR
Pediatr Int; 2007 Dec; 49(6):848-52. PubMed ID: 18045284
[TBL] [Abstract][Full Text] [Related]
33. Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy.
Tsuda N; Yuki N; Mochizuki K; Nagaoka T; Yamashiro M; Omura M; Hikiji K; Kato M
J Med Virol; 2004 Nov; 74(3):406-13. PubMed ID: 15368524
[TBL] [Abstract][Full Text] [Related]
34. Interferon and ribavirin treatment results of patients with HBV-HCV co-infection cured of childhood malignancies.
Urganci N; Gulec S; Dogan S; Nuhoglu A
Int J Infect Dis; 2006 Nov; 10(6):453-7. PubMed ID: 17000127
[TBL] [Abstract][Full Text] [Related]
35. Treatment of pegylated interferon-α2a in chronic hepatitis B patients demonstrating a spontaneous decline in HBV DNA after acute exacerbation.
Cai Q; Chen F; Shao X; Zhang X; Zhao Z; Gao Z
Antivir Ther; 2015; 20(2):217-24. PubMed ID: 25138110
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients.
Durlik M; Gaciong Z; Rowińska D; Rancewicz Z; Lewandowska D; Kozłowska B; Wyzgał J; Soluch L; Walewska-Zielecka B; Rowiński W; Lao M
Transpl Int; 1998; 11 Suppl 1():S135-9. PubMed ID: 9664963
[TBL] [Abstract][Full Text] [Related]
37. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
[TBL] [Abstract][Full Text] [Related]
38. ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.
ter Borg MJ; Hansen BE; Bigot G; Haagmans BL; Janssen HL
J Clin Virol; 2008 Jun; 42(2):160-4. PubMed ID: 18359663
[TBL] [Abstract][Full Text] [Related]
39. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance.
Fukuda R; Ishimura N; Niigaki M; Hamamoto S; Satoh S; Tanaka S; Kushiyama Y; Uchida Y; Ihihara S; Akagi S; Watanabe M; Kinoshita Y
J Med Virol; 1999 Jul; 58(3):201-7. PubMed ID: 10447413
[TBL] [Abstract][Full Text] [Related]
40. Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring.
Lobello S; Lorenzoni U; Vian A; Floreani A; Brunetto MR; Chiaramonte M
J Viral Hepat; 1998 Jan; 5(1):61-6. PubMed ID: 9493518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
